Neutrophil-to-Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries.

导出 OA

翻译打印收藏纠错

作者： Bahira,Shahim ^[1] ; Björn,Redfors ^[1] ; Brian R,Lindman ^[2] ; Shmuel,Chen ^[3] ; Torsten,Dahlen ^[1] ; Tamim,Nazif ^[2] ; Samir,Kapadia ^[4] ; Zachary M,Gertz ^[2] ; Aaron C,Crowley ^[5] ; Ditian,Li ^[6] ; Vinod H,Thourani ^[1] ; Susheel K,Kodali ^[1] ; Alan,Zajarias ^[7] ; Vasilis C,Babaliaros ^[2] ; Robert A,Guyton ^[8] ; Sammy,Elmariah ^[9] ; Howard C,Herrmann ^[9] ; David J,Cohen ^[10] ; Michael J,Mack ^[11] ; Craig R,Smith ^[1] ; Martin B,Leon ^[12] ; Isaac,George ^[13]

作者单位： Clinical Trials Center Cardiovascular Research Foundation New York NY. ^[1] Division of Cardiology NewYork-Presbyterian Hospital/Columbia University Medical Center New York NY. ^[2] Structural Heart and Valve CenterVanderbilt University Medical Center Nashville TN. ^[3] Department of Medicine Karolinska Institutet Solna Sweden. ^[4] Cleveland Clinic Cleveland OH. ^[5] Virginia Commonwealth University Richmond VA. ^[6] Department of Cardiovascular Surgery Marcus Valve CenterPiedmont Heart Institute Atlanta GA. ^[7] Washington University School of Medicine St. Louis MO. ^[8] Emory University School of Medicine Atlanta GA. ^[9] Massachussetts General Hospital and Harvard Medical School Boston MA. ^[10] University of Pennsylvania Philadelphia PA. ^[11] St. Francis Hospital Roslyn NY. ^[12] Baylor Scott & White Health The Heart Hospital Plano Plano TX. ^[13]

关键词 NLR aortic stenosis neutrophil‐to‐lymphocyte ratio surgical aortic valve replacement transcatheter aortic valve replacement